Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AIM TSE:ECF.UN TSE:OLY CVE:WED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMAIM ImmunoTech$2.45-3.7%$5.89$2.33▼$37.80$6.64M0.8865,962 shs57,587 shsECF.UNEast Coast Investment Grade Inc UntC$0.00C$7.04▼C$9.45C$111.12MN/A9,048 shs2,570 shsOLYOlympia Financial GroupC$131.57+0.4%C$125.05C$95.51▼C$134.24C$316.56M0.2640861,915 shs1,427 shsWEDWestaimC$27.73-0.9%C$29.84C$22.80▼C$35.55C$939.11M-0.12981815,783 shs6,629 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMAIM ImmunoTech0.00%-9.37%-16.20%-73.23%-93.11%ECF.UNEast Coast Investment Grade Inc Unt0.00%0.00%0.00%0.00%0.00%OLYOlympia Financial Group0.00%+0.44%+1.61%+19.62%+23.54%WEDWestaim0.00%-3.55%-7.26%-13.90%+602.03%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMAIM ImmunoTech0.7778 of 5 stars3.50.00.00.00.00.00.0ECF.UNEast Coast Investment Grade Inc UntN/AN/AN/AN/AN/AN/AN/AN/AOLYOlympia Financial Group3.1959 of 5 stars3.50.02.50.00.03.31.3WEDWestaim0.0256 of 5 stars0.00.01.70.01.70.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMAIM ImmunoTech 3.00Buy$275.0011,138.25% UpsideECF.UNEast Coast Investment Grade Inc Unt 0.00N/AN/AN/AOLYOlympia Financial Group 3.00BuyC$177.6635.03% UpsideWEDWestaim 0.00N/AC$7.75-72.05% DownsideCurrent Analyst Ratings BreakdownLatest ECF.UN, WED, OLY, and AIM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/26/2025OLYOlympia Financial GroupFundamental ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuyC$177.66(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMAIM ImmunoTech$121K54.78N/AN/A$0.20 per share12.24ECF.UNEast Coast Investment Grade Inc UntN/AN/AN/AN/AN/AN/AOLYOlympia Financial GroupC$101.51M3.12C$11.28 per share11.66C$16.72 per share7.87WEDWestaimC$42.11M22.09C$27.64 per share1.00C$3.89 per share7.12Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMAIM ImmunoTech-$28.96M-$24.68N/AN/AN/A-12,594.21%-421.73%-147.54%N/AECF.UNEast Coast Investment Grade Inc UntN/AN/A0.00N/AN/AN/AN/AN/AN/AOLYOlympia Financial GroupC$24.45MC$9.6113.69∞N/A23.82%64.95%35.88%N/AWEDWestaimC$4.52M-C$1.32N/A∞N/A44.28%7.76%7.60%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMAIM ImmunoTechN/AN/AN/AN/AN/AECF.UNEast Coast Investment Grade Inc UntC$0.485.65%N/AN/AN/AOLYOlympia Financial GroupC$7.205.47%N/A74.92%N/AWEDWestaimC$0.180.65%N/AN/A N/ALatest ECF.UN, WED, OLY, and AIM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/20/2025OLYOlympia Financial GroupMonthlyC$0.605.76%8/20/20258/29/20258/29/20257/22/2025OLYOlympia Financial GroupMonthlyC$0.605.95%7/22/20257/31/20257/31/20256/19/2025OLYOlympia Financial GroupMonthlyC$0.606.28%6/19/20256/30/20256/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIMAIM ImmunoTech0.050.750.75ECF.UNEast Coast Investment Grade Inc UntN/AN/AN/AOLYOlympia Financial Group6.003.321.59WEDWestaimN/AN/A27.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMAIM ImmunoTech12.02%ECF.UNEast Coast Investment Grade Inc UntN/AOLYOlympia Financial Group0.63%WEDWestaim14.04%Insider OwnershipCompanyInsider OwnershipAIMAIM ImmunoTech0.02%ECF.UNEast Coast Investment Grade Inc UntN/AOLYOlympia Financial Group34.63%WEDWestaim9.25%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMAIM ImmunoTech202.71 million68.74 millionNot OptionableECF.UNEast Coast Investment Grade Inc UntN/A13.07 millionN/ANot OptionableOLYOlympia Financial Group3252.41 millionN/ANot OptionableWEDWestaim3,24033.55 millionN/ANot OptionableECF.UN, WED, OLY, and AIM HeadlinesRecent News About These CompaniesWestaim (CVE:WED) Shares Cross Below 200 Day Moving Average - Time to Sell?August 23, 2025 | marketbeat.comWestaim Corporation Reports Q2 2025 Results Amid Strategic TransformationAugust 22, 2025 | msn.comWestaim (CVE:WED) Shares Down 1% - Here's WhyAugust 1, 2025 | marketbeat.comWestaim to Invest AUS$154 Million to Finance AUS$3.9 Billion Insignia AcquisitionJuly 24, 2025 | finance.yahoo.comWestaim Commits AUS$154 Million for Insignia AcquisitionJuly 22, 2025 | tipranks.comAM Best Assigns Credit Ratings to Ceres Life Insurance CompanyJuly 9, 2025 | uk.finance.yahoo.comRetail investors account for 49% of The Westaim Corporation's (CVE:WED) ownership, while private equity firms account for 36%July 4, 2025 | finance.yahoo.comWestaim Corporation Reports Q1 2025 Loss Amid Strategic Acquisition CostsMay 14, 2025 | tipranks.comWestaim and CC Capital Finalize Transformative Insurance and Asset Management DealApril 3, 2025 | tipranks.comWestaim Full Year 2024 Earnings: US$0.75 loss per share (vs US$7.98 profit in FY 2023)March 28, 2025 | finance.yahoo.comWestaim nears completion of CC Capital dealMarch 28, 2025 | insurancebusinessmag.comIWestaim: Q4 Earnings SnapshotMarch 27, 2025 | sfgate.comWestaim Corporation Reports 2024 Financial Results Amid Strategic RestructuringMarch 26, 2025 | tipranks.comWestaim Completes Acquisition of ManhattanLife InsuranceFebruary 5, 2025 | tipranks.comWestaim Appoints Menes Chee as Independent Director Amid Strategic TransformationJanuary 7, 2025 | tipranks.comThe Westaim Corporation to Appoint Menes Chee as Independent DirectorJanuary 7, 2025 | financialpost.comFWestaim Restructures and Relocates to DelawareJanuary 2, 2025 | tipranks.comWestaim Shareholders Approve Major CC Capital DealDecember 19, 2024 | tipranks.comThe Westaim Corporation Shareholders Overwhelmingly Approve CC Capital TransactionDecember 19, 2024 | financialpost.comFThe Westaim Corporation Reminds Shareholders to Cast their Vote for the Upcoming Special MeetingDecember 12, 2024 | financialpost.comFWestaim Names New CFO Amid Strategic ExpansionDecember 2, 2024 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesToll Brothers: A Great Buy and Hold Stock With Risks in 2025By Thomas Hughes | August 21, 20253 Stocks With Monopoly Power—and Minimal CompetitionBy Gabriel Osorio-Mazilli | August 10, 2025Lyft's Billion-Dollar Signal: Why Wall Street Is Betting BigBy Jeffrey Neal Johnson | August 19, 2025AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles DownBy Leo Miller | August 7, 2025Traders Turn Bullish on Housing Stocks Again—3 Leading the WayBy Gabriel Osorio-Mazilli | August 4, 2025ECF.UN, WED, OLY, and AIM Company DescriptionsAIM ImmunoTech NYSE:AIM$2.45 -0.09 (-3.66%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$2.50 +0.06 (+2.37%) As of 08/29/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.East Coast Investment Grade Inc Unt TSE:ECF.UNEast Coast Investment Grade Income Fund is a closed end fixed income fund launched and managed by Arrow Capital Management. The fund is co-managed by East Coast Fund Management Inc. It invests in fixed income markets. East Coast Investment Grade Income Fund is domiciled in Canada.Olympia Financial Group TSE:OLYC$131.57 +0.57 (+0.44%) As of 08/29/2025 03:23 PM EasternOlympia Financial Group Inc is engaged in providing financial services. The company's operating segments are Private Health Services Plan division which markets, sells and administers health and dental benefits to business owners; Investment Account Services division specializes in registered account administration; The Currency and Global Payments division provides corporations and private clients a personalized service for buying and selling foreign currencies; The Exempt Edge division is focused on Onboarding fees; The Corporate and Shareholder Services division, which acts as a cost centre and the Corporate Division.Westaim CVE:WEDC$27.73 -0.26 (-0.93%) As of 08/29/2025 03:59 PM EasternThe Westaim Corporation is a private equity firm specializing in direct and indirect investments through acquisitions, joint ventures, secondary investments both direct and indirect, fund of fund investments, and other arrangements. For direct investments, the firm invests in early venture, mid venture, late venture, middle market, later stage, mature, emerging growth, PIPEs, and buyout transactions. For fund of fund investments, it seeks to invest in private equity funds, venture capital funds, and hedge funds. The firm seeks to provide long term capital to businesses operating in the global financial services industry. It typically acquires controlling interests in businesses. The firm seeks to acquire debt, equity, or derivative securities of both public and private companies. It invests with the objective of providing its shareholders with capital appreciation and real wealth preservation. The firm seeks to provide its portfolio companies with advisory services including, but not limited to, advice on capital allocation, financing strategy, performance measurement and merger and acquisition support. It also seeks to partner with like-minded providers of third party capital to help supplement the firm's own capital, when completing acquisitions. The firm generally seeks to hold its investments for seven to 15 years. The Westaim Corporation was founded in 1996 and is based in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
